Oral Aloe Vera for Treatment of Diabetes Mellitus and Dyslipidemia

Minh Q. Ngo, Pharm.D.; Nancy N. Nguyen, Pharm.D.; Sachin A. Shah, Pharm.D.


Am J Health Syst Pharm. 2010;67(21):1804-1811. 

In This Article


The preponderance of evidence suggests a trend toward benefit from oral aloe vera use in reducing fasting blood glucose concentration and HbA1c. Triglyceride levels also seem to be reduced, although evidence regarding changes in LDL, HDL, and total cholesterol levels is conflicting. The weaknesses in study methods and inconsistency in data do not currently warrant recommendation of oral aloe vera for the management of diabetes mellitus or dyslipidemia.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.